AST: How to Interpret Your Result

What AST Actually Measures

AST, or aspartate aminotransferase, is an intracellular enzyme that catalyzes the transfer of an amino group from aspartate to alpha-ketoglutarate. When cells containing AST are damaged or destroyed, the enzyme leaks into the bloodstream, where a simple blood draw can detect it.

Unlike ALT, which is found almost exclusively in the liver, AST lives in multiple tissues. The liver contains the highest concentration, but cardiac muscle, skeletal muscle, kidneys, and red blood cells all house significant amounts [1]. This dual distribution is clinically important. An isolated AST elevation does not automatically mean liver disease. A patient who ran a marathon the day before blood work may show AST levels two to three times the upper limit of normal purely from muscle breakdown [2]. The 2021 American College of Gastroenterology (ACG) clinical guideline on evaluation of abnormal liver chemistries emphasizes that AST should always be interpreted alongside ALT, alkaline phosphatase, and bilirubin rather than in isolation [3].

Your lab report will list AST in units per liter (U/L). Most commercial laboratories set the adult reference range at 10 to 40 U/L, though some use 8 to 33 U/L [4]. Men tend to run slightly higher than women, and values in healthy newborns can reach 80 U/L without indicating pathology.

Normal AST Ranges by Age and Sex

The "normal" AST range is not one number. It shifts with age, sex, and even the analytical method your lab uses. Knowing where you fall within these ranges matters more than memorizing a single cutoff.

For adult men, most reference laboratories report a normal range of 10 to 40 U/L. Adult women typically show 9 to 32 U/L [4]. The difference reflects greater average muscle mass in men, since skeletal muscle contributes a measurable fraction of circulating AST. Children and adolescents carry higher baseline levels, sometimes up to 60 U/L, because of rapid growth and higher relative muscle turnover [5]. Pregnant women in the third trimester may see mild AST elevations due to physiological changes in hepatic blood flow, though values exceeding 40 U/L in pregnancy warrant evaluation for HELLP syndrome or intrahepatic cholestasis [6].

A 2020 population-based study in Hepatology Communications (N=14,527) found that applying a single universal cutoff of 40 U/L missed subclinical liver disease in 23% of women whose AST fell between 25 and 40 U/L [7]. The ACG guideline now recommends sex-specific upper limits of normal: 33 U/L for men and 25 U/L for women [3]. Ask your provider whether your lab uses updated or traditional thresholds. The distinction can change whether a result gets flagged.

What High AST Means

Elevated AST tells you that cells somewhere in your body have been injured. The degree of elevation and the pattern alongside other markers narrow the list of possibilities considerably.

Mild elevations (less than five times the upper limit of normal, or roughly <200 U/L) are the most common finding. Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) accounts for the largest share. A 2023 meta-analysis in The Lancet Gastroenterology & Hepatology estimated that MASLD affects 38% of adults globally, and mild aminotransferase elevation is often the first laboratory clue [8]. Medications are another frequent cause. Statins, certain antibiotics, antiepileptics, and nonsteroidal anti-inflammatory drugs can all produce AST elevations in the 40 to 120 U/L range [3]. Intense physical exercise, hemolysis during blood draw, and thyroid dysfunction round out the mild-elevation differential.

Moderate elevations (5 to 15 times the upper limit, roughly 200 to 600 U/L) point toward acute hepatitis (viral, autoimmune, or drug-induced), biliary obstruction, or early acetaminophen toxicity [9].

Severe elevations (>1 to 000 U/L) have a short differential. Ischemic hepatitis ("shock liver"), acute acetaminophen overdose, and fulminant viral hepatitis account for the vast majority. A retrospective review of 670 patients with AST >3 to 000 U/L at a tertiary care center found that ischemic hepatitis caused 48% of cases, acetaminophen toxicity caused 29%, and acute viral hepatitis caused 12% [10]. These patients need urgent inpatient evaluation.

The AST/ALT Ratio: A Clinical Shortcut

The ratio of AST to ALT is one of the most useful derived values in hepatology. It costs nothing extra. It requires no additional blood. And it changes the diagnostic direction meaningfully.

An AST/ALT ratio below 1.0 is typical in nonalcoholic fatty liver disease and chronic viral hepatitis (hepatitis B or C without cirrhosis) [3]. The liver is the primary source of both enzymes, but ALT has a longer half-life (approximately 47 hours versus 17 hours for AST), so in slow, ongoing liver injury, ALT tends to accumulate more [11].

A ratio above 2.0 is strongly associated with alcoholic liver disease. The classic teaching holds that alcohol selectively depletes hepatic pyridoxal-5-phosphate (vitamin B6), which is a cofactor required for ALT synthesis more than AST synthesis. The result: ALT drops while AST stays elevated [12]. In a cohort of 271 patients with biopsy-confirmed alcoholic hepatitis, 70% had an AST/ALT ratio exceeding 2.0, and the mean ratio was 2.85 [12].

A ratio above 1.0 that climbs over serial measurements in a patient with known chronic liver disease may signal the transition from fibrosis to cirrhosis, regardless of etiology. The 2023 AASLD Practice Guidance on MASLD notes that a rising AST/ALT ratio in the setting of metabolic risk factors should prompt noninvasive fibrosis assessment with FIB-4 or vibration-controlled transient elastography [13].

Dr. Paul Angulo, whose research established much of the modern understanding of the AST/ALT ratio in NAFLD, wrote in a landmark Gastroenterology paper: "An AST/ALT ratio greater than one in patients with nonalcoholic fatty liver disease independently predicts the presence of advanced hepatic fibrosis" [14]. That observation, published in 1999, has been validated repeatedly in the decades since.

What Low AST Means

Very low AST values get far less clinical attention than elevations. That is appropriate. An AST below 10 U/L is uncommon but rarely dangerous.

Vitamin B6 deficiency can suppress AST production because pyridoxal-5-phosphate serves as a cofactor for the enzyme [15]. Patients on chronic hemodialysis, those with severe malnutrition, and individuals taking isoniazid (which depletes B6) sometimes show AST levels in the single digits. Correcting the B6 deficit typically normalizes AST.

Chronic kidney disease on its own may be associated with lower aminotransferase levels. A study in Kidney International (N=56,204) found that patients with eGFR <30 mL/min had mean AST values 15% to 20% lower than age-matched controls with normal renal function [16]. The clinical significance of this finding remains debated, but it means that "normal" AST in a dialysis patient could be masking underlying liver disease.

Pregnancy in the first and second trimesters tends to produce modestly lower AST values due to hemodilution, though this is physiological and requires no intervention [6].

How to Lower Elevated AST

Bringing down a high AST level means treating whatever is injuring the cells that produce it. There is no supplement or shortcut that lowers AST in isolation without addressing the underlying cause.

If MASLD is the cause, weight loss is the most effective intervention. The FLINT trial showed that a 5% reduction in body weight improved hepatic steatosis, and a 7% to 10% loss improved fibrosis scores [17]. A 2024 study in the New England Journal of Medicine demonstrated that resmetirom (Rezdiffra), the first FDA-approved drug for MASH with fibrosis, reduced ALT and AST by a mean of 24% at 52 weeks compared with placebo [18]. For patients who qualify, GLP-1 receptor agonists like semaglutide have also shown AST reduction. In a phase 2 trial (N=320), semaglutide 0.4 mg daily resolved MASH in 59% of patients versus 17% on placebo, with corresponding aminotransferase normalization [19].

If alcohol is the cause, cessation is the single most impactful step. AST can normalize within weeks to months of abstinence in patients without advanced fibrosis [3].

If medications are responsible, your provider may switch the offending drug, reduce the dose, or monitor more frequently. Statin-related AST elevations above three times the upper limit of normal typically warrant discontinuation per the 2018 ACC/AHA cholesterol guideline, though mild elevations (<3x ULN) are generally considered safe to continue [20].

Regular moderate exercise, independent of weight loss, has been shown to reduce hepatic steatosis and aminotransferase levels. A meta-analysis of 12 randomized trials (N=1,260) in the Journal of Hepatology found that aerobic exercise reduced ALT by a mean of 4.3 U/L and AST by 3.8 U/L, even without significant body weight change [21].

When to Worry and When to Recheck

Not every abnormal AST result demands an immediate workup. Context matters.

The ACG guideline suggests the following approach: if AST is mildly elevated (less than five times the upper limit) and the patient is asymptomatic, repeat the test in one to three months after eliminating confounders like recent exercise, alcohol, or new medications [3]. If elevation persists on recheck, order a focused workup: hepatitis B and C serologies, iron studies, autoimmune markers (ANA, smooth muscle antibody), and a metabolic panel. If the AST/ALT ratio exceeds 2.0, ask specifically about alcohol use. If the patient has metabolic risk factors (BMI >25, type 2 diabetes, dyslipidemia), calculate a FIB-4 score.

"A single mildly elevated aminotransferase value does not require an exhaustive evaluation," states the ACG guideline. "But persistent elevation beyond six months should not be attributed to unexplained causes without a systematic diagnostic assessment" [3].

Urgent situations require faster action. An AST exceeding 1 to 000 U/L, rapidly rising AST over hours to days, or AST elevation accompanied by jaundice, coagulopathy, or altered mental status should trigger same-day or emergency evaluation [9].

AST in the Context of a Complete Liver Panel

AST is one piece of a puzzle. The full liver panel, sometimes called a hepatic function panel or liver chemistry panel, typically includes ALT, alkaline phosphatase (ALP), total and direct bilirubin, albumin, and total protein.

AST and ALT together reflect hepatocellular injury (damage to liver cells themselves). ALP and GGT together reflect cholestatic injury (problems with bile flow). Bilirubin rises when the liver cannot process or excrete it efficiently. Albumin drops when synthetic function deteriorates, a late finding that indicates chronic or severe disease [3].

A pattern of elevated AST and ALT with normal ALP points toward hepatocellular injury: think viral hepatitis, MASLD, autoimmune hepatitis, or drug toxicity. A pattern of elevated ALP with normal or mildly elevated AST and ALT points toward cholestasis: think bile duct obstruction, primary biliary cholangitis, or infiltrative disease. Mixed patterns exist and often require imaging (ultrasound or MRI) to sort out [9].

The De Ritis ratio (AST/ALT) adds another layer, as discussed above. Combining these markers with clinical context, medication history, and risk factors gives your provider a reasonably precise initial picture without needing a liver biopsy in most cases.